Elsewhere online
March 06, 2015

Gates Foundation Ups Investment for New Vaccines

The Bill & Melinda Gates Foundation announced a $52 million investment in the German pharmaceutical firm CureVac, the philanthropy's largest such business stake and a reflection of its growing emphasis on using investments as well as grants to back the development of new medical treatments, Forbes writes.

The Gates financing is part of a $76 million investment round for CureVac, which is pioneering technologies to use mRNA -- a messenger chemical that carries information from genes to the parts of cells that make proteins -- as a basis for drugs and vaccines that, in effect, instruct the body to produce disease defenses. "Technologies like mRNA give us confidence to place big bets for the future," Bill Gates said in a statement.